BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34352676)

  • 1. A pipeline to quantify spinal cord atrophy with deep learning: Application to differentiation of MS and NMOSD patients.
    Toufani H; Vard A; Adibi I
    Phys Med; 2021 Sep; 89():51-62. PubMed ID: 34352676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging.
    Huang C; Chen W; Liu B; Yu R; Chen X; Tang F; Liu J; Lu W
    Front Immunol; 2022; 13():897959. PubMed ID: 35774780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.
    Chien C; Brandt AU; Schmidt F; Bellmann-Strobl J; Ruprecht K; Paul F; Scheel M
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1362-1368. PubMed ID: 29748202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
    Chien C; Scheel M; Schmitz-Hübsch T; Borisow N; Ruprecht K; Bellmann-Strobl J; Paul F; Brandt AU
    Mult Scler; 2019 Dec; 25(14):1926-1936. PubMed ID: 30475082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hua T; Fan H; Duan Y; Tian D; Chen Z; Xu X; Bai Y; Li Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Xu S; Jin Y; Li H; Zhuo Z; Zhang X; Liu Y
    J Neurol; 2024 Jun; 271(6):3595-3609. PubMed ID: 38558149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model.
    Seok JM; Cho W; Chung YH; Ju H; Kim ST; Seong JK; Min JH
    Sci Rep; 2023 Jul; 13(1):11625. PubMed ID: 37468553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks.
    Gros C; De Leener B; Badji A; Maranzano J; Eden D; Dupont SM; Talbott J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Tachibana Y; Hori M; Kamiya K; Chougar L; Stawiarz L; Hillert J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith S; Treaba CA; Mainero C; Lefeuvre J; Reich DS; Nair G; Auclair V; McLaren DG; Martin AR; Fehlings MG; Vahdat S; Khatibi A; Doyon J; Shepherd T; Charlson E; Narayanan S; Cohen-Adad J
    Neuroimage; 2019 Jan; 184():901-915. PubMed ID: 30300751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
    PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
    Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI
    Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Liu Y; Dong D; Zhang L; Zang Y; Duan Y; Qiu X; Huang J; Dong H; Barkhof F; Hu C; Fang M; Tian J; Li K
    Eur Radiol; 2019 Sep; 29(9):4670-4677. PubMed ID: 30770971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord atrophy in neuromyelitis optica spectrum disorders.
    Wang Y; Wang Y; Tan S; Lu Z
    Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Learning-Based Method to Differentiate Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
    Kim H; Lee Y; Kim YH; Lim YM; Lee JS; Woo J; Jang SK; Oh YJ; Kim HW; Lee EJ; Kang DW; Kim KK
    Front Neurol; 2020; 11():599042. PubMed ID: 33329357
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Mariano R; Messina S; Roca-Fernandez A; Leite MI; Kong Y; Palace JA
    Brain; 2021 Feb; 144(1):198-212. PubMed ID: 33206944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Classification of Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions Using Deep Learning.
    Zhuo Z; Zhang J; Duan Y; Qu L; Feng C; Huang X; Cheng D; Xu X; Sun T; Li Z; Guo X; Gong X; Wang Y; Jia W; Tian D; Zhang X; Shi F; Haller S; Barkhof F; Ye C; Liu Y
    Radiol Artif Intell; 2022 Nov; 4(6):e210292. PubMed ID: 36523644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.